Brain as a unique antisense environment

Antisense and Nucleic Acid Drug Development

Volumn 9, Issue 1, 1999, Pages 105-116

  Szklarczyk, Arkadiusz W ^a   Kaczmarek, Leszek ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CARRIER PROTEIN; CYTOKINE; ION CHANNEL; NEUROPEPTIDE; NEUROTRANSMITTER RECEPTOR; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; TRANSCRIPTION FACTOR;

BRAIN; GENE REPRESSION; PRIORITY JOURNAL; REVIEW;

MAMMALIA;

EID: 0033065251     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1999.9.105     Document Type: Review

References (9)

1. ABRAHAM, W.C., LOGAN, B., THOMPSON, V.L., WILLIAMS, J.M., and TATE, W.P. (1997). Sequence-independent effects of phosphorothiolated oligonucleotides on synaptic transmission and excitability in the hippocampus in vivo. Neuropharmacology 36, 345-352.
2. ADAMS, J.U., CHEN, X., DERIEL, J.K., ADLER, M.W., and LIUCHEN, L.Y. (1994). Intracerebroventricular treatment with an antisense oligodeoxynucleotide to kappa-opioid receptors inhibited kappa-agonist-induced analgesia in rats. Brain Res. 667, 129-132.
3. AGRAWAL, S., TEMSAMANI, J., and TANG, Y.J. (1991). Pharmacokinetics, biodistribution and stability of oligodeoxynucleotide phosphorotioates in mice. Proc. Natl. Acad. Sci. USA 88, 7595-7599.
4. CHIU, T.H., DUN, S.L., TANG, H., and DUN, N.J. (1994). c-fos antisense attenuates Fos expression in rat central neurons induced by hemorrhage. Neuroreport 5, 2178-2180.
5. CIRELLI, C., POMPEIANO, M., ARRIGHI, P., and TONONI, G. (1995). Sleep-waking changes after c-fos antisense injections in the medial preoptic area. Neuroreport 6, 801-805.
6. CROCKER, S.J., MORELLI, M., WIGLE, N., NAKABEPPU, Y., and ROBERTSON, G.S. (1998). D1-Receptor-related priming is attenuated by antisense-meditated "knockdown" of fosB expression. Brain Res. Mol. Brain Res. 53, 69-77.
7. CROOKE, R.M. (1991). In vitro toxicology and pharmacokinetics of antisense oligonucleotides. Anticancer Drug Des. 6, 609-646.
8. CROOKE, R.M., GRAHAM, M.J., COOKE, M.E., and CROOKE, S.T. (1995). In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides. J. Pharmacol. Exp. Ther. 275, 462-473.
9. ZIOLKOWSKA, B., PRZEWLOCKA, B., MIKA, J., LABUZ, D., and PRZEWLOCKI, R. (1998). Evidence for fos involvement in the regulation of proenkephalin and prodynorphin gene expression in the rat hippocampus. Brain Res. Mol. Brain Res. 54, 243-251.